European Archives - Page 882 of 981 - European Medical Journal

EMJ

Defining the elements of the acute oncology nursing role

At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Ali Hodge, Advanced Nurse Practitioner for Acute Oncology at The Royal…

EMJ

Chemotherapy-induced nausea and vomiting – a nurse’s perspective

At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Annie Young, SRN, PhD, Professor of Nursing, University of Warwick…

EMJ

Physical activity, obesity and cancer

Martin Wiseman, MD talks about how the environment we live in determines the patterns of cancer across the world. There is now an increasingly large…

EMJ

The use of supplements to complement a healthy and balanced diet for prostate cancer patients

Robert Thomas, MbChb, MRCP, MD, FRCR, discusses the results of the Pomi-T clinical trial. The study focused on the effects of Pomi-T on prostate-specific…

EMJ

Strategies to cope with cancer therapy side-effects

Robert Thomas, MbChb, MRCP, MD, FRCR, discusses non-medicinal strategies to help cancer patients cope with cancer therapy side-effects. Prof. Robert…

EMJ

The importance of a healthy and balanced diet for cancer patients

Robert Thomas, MbChb, MRCP, MD, FRCR, discusses the importance of having a healthy diet for cancer patients. Prof. Robert Thomas suggests that cancer…

EMJ

Addressing patient safety at the UKONS Annual Conference 2015

At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, which attracts cancer nurses from around the United Kingdom and beyond…

EMJ

Molecular drivers of metastatic disease in breast cancer

At the European Cancer Congress (ECC) 2015, Giuseppe Curigliano, MD, PhD, of Istituto Europeo di Oncologia, Milan, Italy, explains that genetic…

EMJ

Clinical implications of malnourishment in cancer care

At the European Cancer Congress (ECC) 2015, Riccardo A. Audisio, MD, FRCS, of the University of Liverpool, St. Helens Teaching Hospital, St. Helens, UK…

EMJ

Nivolumab and cabozantinib versus standard of care in renal cell carcinoma

Thomas Powles, MBBS, MRCP, MD, of Barts and The London School of Medicine and Dentistry, London, UK, discusses the results of clinical trials reported…